Kolmar BNH Co., Ltd. (200130.KQ)

KRW 11510.0

(-2.29%)

Total Liabilities Summary of Kolmar BNH Co., Ltd.

Kolmar BNH Co., Ltd.'s latest annual total liabilities in 2023 was 298.2 Billion KRW , up 39.2% from previous year.
Kolmar BNH Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 309.01 Billion KRW , down -2.01% from previous quarter.
Kolmar BNH Co., Ltd. reported annual total liabilities of 214.23 Billion KRW in 2022, up 41.64% from previous year.
Kolmar BNH Co., Ltd. reported annual total liabilities of 151.24 Billion KRW in 2021, down -16.14% from previous year.
Kolmar BNH Co., Ltd. reported quarterly total liabilities of 315.35 Billion KRW for 2024 Q1, up 5.75% from previous quarter.
Kolmar BNH Co., Ltd. reported quarterly total liabilities of 298.2 Billion KRW for 2023 Q4, up 9.68% from previous quarter.

Annual Total Liabilities Chart of Kolmar BNH Co., Ltd. (2023 - 2014)

Historical Annual Total Liabilities of Kolmar BNH Co., Ltd. (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	298.2 Billion KRW	39.2%
2022	214.23 Billion KRW	41.64%
2021	151.24 Billion KRW	-16.14%
2020	180.36 Billion KRW	36.82%
2019	131.82 Billion KRW	55.07%
2018	85 Billion KRW	-8.86%
2017	93.27 Billion KRW	199.23%
2016	31.17 Billion KRW	14.8%
2015	27.15 Billion KRW	819.65%
2014	2.95 Billion KRW	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	309.01 Billion KRW	-2.01%
2024 Q1	315.35 Billion KRW	5.75%
2023 Q4	298.2 Billion KRW	9.68%
2023 Q1	268.54 Billion KRW	25.35%
2023 Q3	271.88 Billion KRW	-4.45%
2023 FY	298.2 Billion KRW	39.2%
2023 Q2	284.54 Billion KRW	5.96%
2022 FY	214.23 Billion KRW	41.64%
2022 Q4	214.23 Billion KRW	14.41%
2022 Q3	187.25 Billion KRW	-0.3%
2022 Q1	177.07 Billion KRW	17.08%
2022 Q2	187.81 Billion KRW	6.06%
2021 FY	151.24 Billion KRW	-16.14%
2021 Q1	204.6 Billion KRW	13.44%
2021 Q2	163.98 Billion KRW	-19.86%
2021 Q4	151.24 Billion KRW	14.9%
2021 Q3	131.63 Billion KRW	-19.73%
2020 Q1	150.93 Billion KRW	14.5%
2020 Q3	148.16 Billion KRW	-6.99%
2020 Q4	180.36 Billion KRW	21.73%
2020 FY	180.36 Billion KRW	36.82%
2020 Q2	159.29 Billion KRW	5.54%
2019 Q1	110.54 Billion KRW	35.6%
2019 FY	131.82 Billion KRW	55.07%
2019 Q3	112.71 Billion KRW	6.97%
2019 Q2	105.36 Billion KRW	-4.69%
2019 Q4	131.82 Billion KRW	16.95%
2018 FY	85 Billion KRW	-8.86%
2018 Q1	95.94 Billion KRW	2.87%
2018 Q2	75.93 Billion KRW	-20.86%
2018 Q3	95.6 Billion KRW	25.91%
2018 Q4	81.52 Billion KRW	-14.73%
2017 Q3	88.4 Billion KRW	0.22%
2017 Q1	42.85 Billion KRW	48.99%
2017 FY	93.27 Billion KRW	199.23%
2017 Q2	88.2 Billion KRW	105.83%
2017 Q4	93.27 Billion KRW	5.51%
2016 Q2	36.23 Billion KRW	2.9%
2016 Q4	28.76 Billion KRW	10.7%
2016 Q3	25.98 Billion KRW	-28.3%
2016 Q1	35.21 Billion KRW	38.13%
2016 FY	31.17 Billion KRW	14.8%
2015 Q2	31.69 Billion KRW	4.57%
2015 Q3	28.08 Billion KRW	-11.39%
2015 Q4	25.49 Billion KRW	-9.22%
2015 FY	27.15 Billion KRW	819.65%
2015 Q1	30.31 Billion KRW	0.0%
2014 FY	2.95 Billion KRW	0.0%

Peer Total Liabilities Comparison of Kolmar BNH Co., Ltd.

Name	Total Liabilities	Total Liabilities Difference
NeoPharm CO., LTD.	19.3 Billion KRW	-1444.504%